TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2021

Lenalidomide-Epoetin Alfa Versus Lenalidomide Monotherapy in Myelodysplastic Syndromes Refractory to Recombinant Erythropoietin.

Alan F List et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.